Choosing an epidemiological model structure for the economic evaluation of non-communicable disease public health interventions

被引:67
|
作者
Briggs, Adam D. M. [1 ]
Wolstenholme, Jane [2 ]
Blakely, Tony [3 ]
Scarborough, Peter [1 ]
机构
[1] Univ Oxford, Nuffield Dept Populat Hlth, BHF Ctr Populat Approaches Noncommunicable Dis Pr, Old Rd Campus, Oxford OX3 7LF, England
[2] Univ Oxford, Nuffield Dept Populat Hlth, Hlth Econ Res Ctr HERC, Old Rd Campus, Oxford OX3 7LF, England
[3] Univ Otago, Dept Publ Hlth, Hlth Inequal Res Programme HIRP, Wellington, New Zealand
来源
POPULATION HEALTH METRICS | 2016年 / 14卷
基金
英国惠康基金;
关键词
Modeling; Cost-effectiveness; Non-communicable disease; Economics; Public health; COST-EFFECTIVENESS ANALYSIS; LIFE-STYLE INTERVENTION; DIABETES PREVENTION PROGRAM; IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; SMOKING-CESSATION; SIMULATION-MODEL; STATIN THERAPY; MARKOV MODEL; STRATEGIES;
D O I
10.1186/s12963-016-0085-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Non-communicable diseases are the leading global causes of mortality and morbidity. Growing pressures on health services and on social care have led to increasing calls for a greater emphasis to be placed on prevention. In order for decisionmakers to make informed judgements about how to best spend finite public health resources, they must be able to quantify the anticipated costs, benefits, and opportunity costs of each prevention option available. This review presents a taxonomy of epidemiological model structures and applies it to the economic evaluation of public health interventions for non-communicable diseases. Through a novel discussion of the pros and cons of model structures and examples of their application to public health interventions, it suggests that individual-level models may be better than population-level models for estimating the effects of population heterogeneity. Furthermore, model structures allowing for interactions between populations, their environment, and time are often better suited to complex multifaceted interventions. Other influences on the choice of model structure include time and available resources, and the availability and relevance of previously developed models. This review will help guide modelers in the emerging field of public health economic modeling of non-communicable diseases.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Systematic literature review on reinforcement learning in non-communicable disease interventions
    Zhao, Yanfeng
    Chaw, Jun Kit
    Liu, Lin
    Chaw, Sook Hui
    Ang, Mei Choo
    Ting, Tin Tin
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2024, 154
  • [22] Why the communicable/non-communicable disease dichotomy is problematic for public health control strategies: implications of multimorbidity for health systems in an era of health transition
    Oni, Tolu
    Unwin, Nigel
    INTERNATIONAL HEALTH, 2015, 7 (06): : 390 - 399
  • [23] Non-Pharmacological Interventions for the Management of Chronic Health Conditions and Non-Communicable Diseases
    Castellano-Tejedor, Carmina
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (14)
  • [24] Kidney health within the broader non-communicable disease agenda
    Slama, Slim
    Luyckx, Valerie A.
    Hemmingsen, Bianca
    NATURE REVIEWS NEPHROLOGY, 2024, 20 (07) : 424 - 425
  • [25] Interventions integrating non-communicable disease prevention and reproductive, maternal, newborn, and child health: A systematic review
    Kikuchi, Kimiyo
    Ayer, Rakesh
    Okawa, Sumiyo
    Nishikitani, Mariko
    Yokota, Fumihiko
    Jimba, Masamine
    Nakashima, Naoki
    BIOSCIENCE TRENDS, 2018, 12 (02) : 116 - 125
  • [26] Global Health Governance and the Challenge of Chronic, Non-Communicable Disease
    Magnusson, Roger S.
    JOURNAL OF LAW MEDICINE & ETHICS, 2010, 38 (03): : 490 - 507
  • [27] Burden of non-communicable diseases among the Orang Asli community and patient satisfaction on non-communicable diseases management at public health facilities
    Netty Darwina
    Sharifa Ezat Wan Puteh
    BMC Public Health, 12 (Suppl 2)
  • [28] Using economic evidence to support policy decisions to fund interventions for non-communicable diseases
    Bertram, Melanie
    Banatvala, Nick
    Kulikov, Alexey
    Belausteguigoitia, Itziar
    Sandoval, Rosa
    Hennis, Anselm
    Webb, Douglas
    Tarlton, Dudley
    BMJ-BRITISH MEDICAL JOURNAL, 2019, 365
  • [29] Non-Communicable Disease Preventive Screening by HIV Care Model
    Rhodes, Corinne M.
    Chang, Yuchiao
    Regan, Susan
    Triant, Virginia A.
    PLOS ONE, 2017, 12 (01):
  • [30] Non-communicable Diseases in India: The Growing Public Health Challenge and the Role of Health Insurance
    Kiranmayi, Vootukuri
    Kumar, K. S. Venkateswara
    Naik, Suresh
    HEALTH BEHAVIOR AND POLICY REVIEW, 2023, 10 (06): : 1422 - 1433